AskAt received a Notice of Allowance issued on August 17, 2020 from the Mexican Patent and Trademark Office (MPTO) in connection with Application No.MX/a/2018/005715, a use patent for AskAt’s EP4 receptor antagonists in the treatment of NASH-associated liver cancer.